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Abstract
Introduction and hypothesis Our study aimed to identify
the rate of suture complications over a 5-year period using
braided permanent suture for uterosacral ligament suspen-
sion (USLS) surgery.
Methods We reviewed the medical records of patients who
underwent vaginal uterosacral ligament suspensions using
braided polyester suture. Outcome measures included rate
and timing of suture complications, patient symptoms post-
operatively, efficacy of treatment modalities and surgical
success.
Results Eighty-three patients had undergone USLS with
braided, polyester suture over the study period that met
inclusion criteria. Thirty-seven patients (44.6%) had suture-
related complications post-operatively with a mean follow-
up of 10.4 months. When only silver nitrate was applied,
16.7% improved, and when the suture was cut in clinic,
77.8% resolved.
Conclusions Permanent polyester braided suture for sus-
pension of vaginal vault may lead to an unacceptably high
suture erosion rate, cutting the suture in clinic results in the
highest resolution.
Keywords Polyestersuture.Suturecomplications.
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Introduction
Uterine and vaginal vault prolapse affects a large percent-
age of our aging population. Apical prolapse remains an
important surgical challenge, with a significant percentage
of patients requiring re-operation within a few years.
Multiple surgical approaches, both vaginal and abdominal,
have been used to treat this bothersome condition. More
recently, mesh augmentation using pre-made kits have
gained popularity for their ease and rapidity of placement.
However, these techniques have not undergone rigorous
study for short- and long-term complications. One popular
approach to apical surgery is the uterosacral ligament
suspension (USLS). It requires an intimate understanding
of female pelvic anatomy and has been investigated by both
retrospective and randomized studies. Researchers have
found a 2–13% rate of recurrent vault prolapse. However,
as with many surgical procedures, no uniform or standard-
ized surgical approach has been established that improves
outcome and reduces complications. No consensus exists
on the types of sutures to use, how closely the sutures
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DOI 10.1007/s00192-010-1109-1should be placed to the vaginal vault, or how many sutures
should be placed on each side. Surgeons have reported
using monofilament, delayed absorbable and permanent
polyester sutures. Many believe that permanent suture will
result in a more durable repair; however, no systematic
comparisons have been made with other suture types. The
aimofthisstudywastoreportthesuturerelatedcomplications
in patients undergoing uterosacral ligament suspension with
permanentbraidedpolyestersuture.Oursecondaryaimwasto
examine the rate of prolapse recurrence.
Materials and methods
We performed a retrospective cohort study of patients who
underwent vaginal uterosacral ligament suspensions at
Harbor UCLA Medical Center between March 2003 and
March 2008. Institutional review board approval was
obtained. All patients who had a vaginal approach were
eligible for the study. Patients were excluded if they had
abdominal or laparoscopic suspensions or had less than a
4-week follow-up. We gathered demographic data including
age, parity, medical comorbidities, previous pelvic and
urogynecologic procedures, and use of vaginal or oral
estrogens from patient medical records. Intra-operative and
post-operative complications, follow-up treatment, and
post-operative prolapse recurrence and incontinence were
abstracted from patient charts.
All patients underwent pre-operative pelvic examination.
Pelvic organ prolapse was quantified using the Baden–
Walker halfway system from 2003 to 2006 and the pelvic
organ prolapse quantification system [1] from 2006 to
2008. Each subject underwent urodynamic assessment
that included retrograde multichannel urethrocystometry,
passive urethral pressure profilometry, cough and valsalva
leak point pressures, simple uroflowmetry, post-void residual
volume determination, and cystourethroscopy. Leak point
pressures were evaluated both with and without prolapse
reduced with two fox swabs to identify patients with occult
incontinence.
Fellows and residents operated on patients in the
Division of Pelvic Medicine and Reconstructive Surgery
under the supervision of the two senior faculty members at
our institution. Patients were given pre-operative antibiotics
and sequential compression stockings for deep vein throm-
bosis prophylaxis. Once the hysterectomy with or without
oopherectomy was performed, a moist laparotomy sponge
was placed into the posterior cul-de-sac. Two Breisky-
Navratil retractors were placed to protect the pelvic sidewall
and help with visualization and palpation of the uterosacral
ligament.The uterosacral ligamentwas identifiedandgrasped
1 cm medial and posterior to the ischial spine with an allis
clamp. A No. 0 permanent braided polyester suture (Ticron,
Tyco, Norwalk, CT, USA) was placed laterally to medially at
this location and a second suture placed 1 cm cephalad to the
first. This was repeated on the contralateral side. Once the
sutures were secured, indigo carmine was injected intra-
vascularly and cystoscopy performed. We placed lateral and
medial tension on the suspension sutures while confirming
bilateral ureteral efflux. Additional procedures were per-
formed to repair defects in the anterior wall in a site-specific
manner without the use of mesh. Patients who were identified
with urodynamic stress or mixed incontinence underwent
a sling procedure with Advantage* or Obtryx* (Boston
Scientific Natwick, MA, USA) device using standardized
techniques. After these procedures were performed, the USL
sutureswereattachedsequentiallytotheanteriorandposterior
vaginal cuff while avoiding vaginal epithelium. Care was
taken to stay 1 to 1.5 cm away from the outside margin of the
cuff. The medial USL sutures were then tied before the lateral
ones. Incontinence procedures and posterior compartment
repairs were performed after repair of the anterior compart-
ment, apical suspension procedure, and cuff closure, when
appropriate. Irrigation was performed and the cuff was closed
with interrupted No. 0 delayed absorbable sutures.
Patients were evaluated at 1 week, 6 weeks, 3 months,
and 1 year. At each post-operative visit, patients were asked
about incontinence, discharge, or bleeding. Suture erosion
was defined as suture visible at the cuff greater than 6 weeks
after surgery. Patients with suture-related complications
underwent one of four possible treatments; observation, silver
nitrate application, suture removal in clinic, or suture removal
in the operating room. The type of treatment was based on
clinician preference and severity of symptoms. Vaginal
estrogen was given at the discretion of the physician. If
outpatient interventions failed, the patient was ultimately
taken to the operating room for suture removal and partial
colpocleisis of the area of suture exposure.
Outcome measures included rate and timing of suture
complications, patient symptoms, efficacy of treatment
modalities, and surgical success. Recurrent prolapse was
defined as Stage II or greater prolapse in any one
compartment. We used basic descriptive statistics and chi-
square analysis for evaluation of discrete variables. Data
was analyzed using SigmatStat 3.5 (SigmaStat, Ashburn,
VA, USA)
Results
Ninety-three patients underwent uterosacral ligament sus-
pension with permanent braided, polyester suture over the
5-year study period. Four patients with abdominal USLS,
three with laparoscopic USLS, and three patients with less
than 4 weeks follow-up were excluded. The clinical and
demographic characteristics of the 83 patients included in
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deviation) age at surgery and mean parity of the 83 patients
included in the analysis was 54.1±9.9 (range 37–76) and 4
(range of 0–16), respectively. Approximately 56 (67.5%)
patients were post-menopausal and 71.0% of our patient
population was Hispanic. Eighty-one patients (97.6%) had
a concurrent hysterectomy and 53 patients (63.9%) had
anterior colporrhaphies. Mean blood loss was 301.5 cc
(±199). Median length of hospitalization was one day
(mean 1.52, range 1–5, SD=0.088).
Peri-operative complications occurred in 19 patients
(22.9%; Table 2). Surgical complications included blood
loss requiring transfusion (two patients), fever [2], cuff
abscess [1], and ureteral injury requiring stent placement
[3]. Six (7.2%) additional patients had ureteral kinking
identified during intra-operative cystoscopy and the offend-
ing suture was removed and replaced without further event.
Post-operatively, two patients complained of buttock pain
and three complained of leg numbness.
Two patients had new and ten patients had recurrent
prolapse (14.5%) noted at their post-operative visit and
none underwent repeat surgery at our institution. Mean
follow-up was 10.4 months (range 1.13–62). The two patients
with new prolapse had anterior vaginal wall prolapse and
recurrent prolapse occurred in the anterior compartment
(eight, 9.6%), posterior compartment (three, 3.6%), and apex
in one patient (1.2%). Forty patients (48.2%) complained of
stress incontinence symptoms pre-operatively, six of which
had negative urodynamics and two who declined surgery.
Patientswhohadconcomitantslingswiththeir prolapserepair
had symptomatic improvement in their symptoms in 93.8%
(30/32) of cases.
Thirty-seven patients (44.6%) had suture-related com-
plications noted at their 6–8-week visit. Thirty of the 37
patients (36.1%) had suture exposure and seven patients
(8.4%) were found to have only granulation tissue at the
cuff. Patients with suture-related complications presented
for routine follow-up with no symptoms (51.3%), vaginal
bleeding (40.5%), and discharge (8.2%). In twenty-four
patients, suture was visible by their 3-month visit (range
2.53–9.8; 64.9%).
At the time of this audit, 48.6% (18/37) had resolution of
their suture-related complications and 19 patients did not.
Of these 19 patients, 11 were lost to follow-up. Seven of the
11 patients who were lost to follow-up were asymptomatic
(63.6%) at the time of their last visit. Seven of the total 37
patients had only granulation tissue noted, with three of
these patients showing resolution (3/7=42%) after silver
nitrate was applied, the other four did not return to clinic.
Of the 30 patients with suture visible at the cuff, patients
were either managed conservatively with observation, silver
nitrate only, or silver nitrate and suture removal in clinic.
Only one of six (16.7%) patients with suture visible at the
vaginal cuff improved when only silver nitrate was applied
and 77.8% resolved (7/9) when the suture was cut in clinic.
Only 6/14 (42.8%) patients resolved when nothing was
done (p=0.36). One additional patient had suture removed
in the OR with resolution of her symptoms. Suture on
average was cut 4.3 months after surgery (SD±113 days).
One patient had recurrent prolapse that had suture cut 1/10
(10%). These patients were followed on average 5.58 months
(±20.5) after the suture was cut.
Univariate analysis showed no increased risk of hyper-
tension or diabetes in the group with suture complications.
Also, menopausal status and age did not significantly
impact suture complications and there was no statistically
significant difference between patients with and without
suture erosion (p=0.2 and p=0.85, respectively). There was
no difference in patients who did and did not receive post-
operative estrogen (p=0.89). Length of hospitalization did
not differ in patients with (17 1 day, 19 greater than 1 day)
and without suture complications (32 1 day, 15 greater than
1 day; p=0.29).
Type of concomitant procedure was not shown to impact
development of suture complications. Patients undergoing
posterior repairs (p=0.89), anterior repairs (p=0.93), slings
(p=0.46), or patients undergoing more than three proce-
dures at one time (p=0.36), did not show a difference in
rate of suture complication (Table 3).
Discussion
Few studies have evaluated the most effective and safe
suture for uterosacral ligament vault suspension (Table 4).
Although performed for over 50 years, the technique has
not been refined with robust comparative studies and most
Table 1 Summary data
Summary data N
Cases 93
Excluded 10
Analyzed 83
Age (±SD) 54 (±9.9)
Mean follow-up (range) 10.4 (1.1, 62 months)
Patients with prior surgery 2 (2.4%)
Patient with prior hysterectomy 2 (2.4%)
Post-menopausal (%) 56 (67.5%)
Ethnicity
Hispanic 59 (71.0%)
Black 10 (12.0%)
White 7 (8.4%)
Asian 6 (7.2%)
Other 1 (1.2%)
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our study, there were a significant percentage of patients
who developed either suture exposure or cuff granulation
tissue post-operatively (44.6%) while using permanent
braided suture. Two previous studies have evaluated the
rate of suture complications in patients undergoing vaginal
surgery with similarly high rates of erosion. Toglia [2]
found that patients undergoing sacrospinous ligament
suspension with the same suture had a 36% rate of suture
complications. Seventy percent of symptomatic patients
required suture removal and 74% presented with vaginal
bleeding. Our patients also presented with vaginal bleeding
and discharge and the most effective treatment ultimately
was complete suture removal.
Luck et al. [3] also found a high rate of suture com-
plications (31.3%) when using 2–0 permanent braided
suture in posterior vaginal wall repairs, while only 9%
had suture complications when using absorbable suture. In
addition, patients who had sphincteroplasties at the time of
surgery with permanent suture were at additional risk for
wound breakdown and suture complications. They found
that wound disruptions occurred earlier with absorbable
suture (median 20 days) as compared to permanent suture
(median 53 days). Our findings, in addition to these published
reports, add substantial evidence that the use of permanent
braided suture at the suture line in vaginal procedures leads to
bothersome symptoms and a high suture complication rate.
Our paper reports suture complications in patientsundergoing
USLS procedures; however, as evidenced by these publica-
tions, permanent suture can cause problems in other types of
vaginal procedures as well.
Other authors have reported outcomes from USLS
procedures and type of suture used for these procedures
varies widely. However, few have reported specifically
on suture complications. Surgeons have used delayed
absorbable [4–8], permanent monofilament [9] and perma-
nent braided suture [10] with similar rate of recurrent
prolapse. Aronson [11] was the only author who used
braided suture and switched from 1–0 polyglyactic acid to
monofilament polydiaxanone during the study, however did
not indicate a reason. This was presumably done for suture
complications.
The reasons for suture complications are manifold.
As the vaginal cuff is usually poorly vascularized post-
surgically in post-menopausal women, there is a high risk
of infection and healing problems. Foreign tissue reaction
and chronic infection may lead to suture exposure and
granulation tissue. Also, the cuff is often denuded of its
peritoneum during hysterectomy and entrance into the
pelvic cavity, which may impact wound healing. One
option is to create clean margins by excising the cuff, prior
to placing the sutures. Every effort should be taken by the
surgeon to place the suture away from the cuff when
passing through the posterior and anterior vaginal cuff.
Ticron* is known for its tensile strength, but may have
increased reactivity compared to monofilament suture such
as polypropolene. It is likely that braided permanent suture
inherently results in more suture complications in vaginal
procedures, as compared to monofilament sutures. Some
Table 3 Concomitant procedures
Procedure N Percent
TVH 81 97.5
Anterior 53 63.9
With graft 7 8.4
Posterior 45 54.2
Anterior and posterior 27 32.5
Sling 31 37.3
BSO/USO 12 14.5
Complication N (%) Type N (%)
Suture complications 37 patients (44.6%) Visible suture at cuff 30 (36.1%)
Granulation tissue only 7 (8.4%)
Post-operative prolapse 12 patients (14.5%) Anterior compartment 8 (9.6%)
Posterior compartment 3 (3.6%)
Apical 1 (1.2%)
Other peri-operative
complications
19 patients (22.9%) Cuff abscess 1
Transfusion 2 (2.4%)
Fever 2 (2.4%)
Buttock pain 2 (2.4%)
Leg numbness 3 (3.6%)
Ureteral kinking requiring stents 3 (3.6%)
Ureteral kinking identified
intra-op with resolution
6 (7.2%)
Table 2 Pre-operative compli-
cations and outcomes
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results [2], claiming that scarring takes place that keeps the
vault suspended as the suture breaks down [12]. Wheeler
[9] chooses monofilament polypropylene sutures and places
only one suture on each side and claims that this results in
less devascularization at the vaginal cuff. After reviewing
our own results, we have stopped using Ticron* suture and
now all surgeons use polytrimethylene carbonate (Coviden
synecture, Norwalk Connecticut) for vault suspension with
good preliminary results.
There was also a significant risk of ureteral entrapment
when the uterosacral ligament was suspended to the vaginal
vault, as seen with previous studies [6, 11]. Six patients
required release of the suture intra-operatively with no
sequela and three patients required stent placement. No
patients needed ureteral re-implantation or repair. Based on
these findings, we have modified our technique, placing a
single throw securing the uterosacral ligament prior to
cystoscopy. We believe that simply placing tension on the
sutures during cystoscopy may not completely occlude an
entrapped ureter in some cases.
The strengths of this study included the large number of
patients with suture complications, allowing a glimpse into
the natural history of suture erosion and cuff complications
with different treatment approaches. Visualized suture or
granulation suture may resolve if seen immediately post-
operatively, however those presenting greater than 3 months
after surgery may require intervention and suture removal.
A few patients were followed for almost 3 or 4 years, and
their suture complications did not resolve without treat-
ment. Physicians are often uncertain of the natural course of
suture exposure. As suture exposures likely will not resolve
with time, as evidenced by the majority of our patients
needing suture removal, it is recommended to remove
suture at the time of visualization. Chronic infection and
granulation tissue formationw i l lr e s u l ti nc o n t i n u e d
problems with bleeding and discomfort.
The weakness of this study was the retrospective design
and the inconsistent patient follow-up. Since level of
physician experience differed at the post-operative visit,
recurrent vault prolapse may have been underestimated. It
was also impossible to know why physicians chose a
Table 4 Overview of uterosacral ligament vaginal vault suspension studies
Author Type of suture Suture placement Complications Cuff Closure/Cystoscopy Success Rate
Amunsden
et al. [7]
1 polyglactin or 0
polygylconate
1st—at level of ischial spine;
2nd—more cephalad
then first
1 transfusion Not commented.
Cystoscopy—before
tying sutures
27/33 (82%) patient
satisfaction; 94%
objective cure
Aronson
et al. [11]
1-0 braided polyglyactic
acid, switched to 1-0
monofilament poly-
diaxanone; 3 sutures
bilaterally
Suture placed “deep”
dorsally and posterioraly in
the pelvis, through
pararectal portion of
ligament
24 (5.9%) blood
transfusions; 2 partial
SBO; 1 vaginal cuff
abscess; 1 patient had
ureteral injury
Not mentioned timing of
cystoscopy or closure
style
Not mentioned
Barber
et al. [6]
Monofilament and 1–0
delayed absorbable
monofilament; 2
sutures bilaterally
Sutures are placed at the
level of ischial spine and
1 cm above
5/46 (11%) ureteral
injury
Interrupted delayed
absorbable; Cystoscopy
after tying suture, but
before attaching to cuff
90% objective
Jenkins [4]1 –0 delayed absorbable
or monofilament; 2
sutures bilaterally
Placed into the medial/
posterior/dorsal aspect of
the USL; 2nd suture placed
lateral to the first
3/50 (6%) suture
erosion
Closed with delayed
absorbable suture;
Cystoscopy not
performed
48/50 (96%). Failures
were asymptomatic
cystoceles
Karram
et al. [5]
0 polypropylene; 2–4
bilaterally delayed
absorbable to suspend
cuff
USL palpated posterior and
medial to ischial spine and
placed above spine with
polypropelene and delayed
absorbable to suspend cuff
5/168 ureteral injury
(2.4%); 1 small bowel
injury; 1 pelvic
abscess
Not discussed.
Cystoscopy performed;
uncertain timing
Patient satisfaction
150/168 (89%)
Schull
et al. [10]
Non-absorbable braided;
3 sutures bilaterally
USL identified posterior and
medial to ischial spines at 4
and 8 o’ clock. Needles
passed lateral to medial
1% transfusion, 1%
ureteral injury/kinking
rate, and 0.3% post-
operative death rate
Continuous delayed
absorbable; cystoscopy—
before and after tying
suspensory sutures
251/289 (87%)
objective
Silva
et al. [8]
Same as Karram Same as Karram 15.3% with surgical
failure; no ureteral
injuries
Not discussed; cystoscopy
performed; uncertain
timing
84.7% objective
Wheeler
et al. [9]
Monofilament
polypropolene; 1 suture
bilaterally
Placed through the
peritoneum and adjacent to
the ligament 1 cm cephalad
and at the same posterior
level as the ischial spine
No ureteral injuries Continuous running;
cystoscopy after cuff
closure
Patient satisfaction
88.9%
Int Urogynecol J (2010) 21:813–818 817certain intervention, and severity of findings or patient
symptoms may have affected success of their intervention. A
larger study size might have been able to identify differences
between study groups in terms of age, blood loss, diabetes,
and menopausal status. Our study was not powered to make
meaningful analysis of these risk factors.
It is time to start fine-tuning our technique of surgical
procedures like the uterosacral ligament that have been
performed for decades. A randomized controlled trial that
compares surgical techniques, suture type, and outcomes
can greatly contribute to guiding surgeon practice. Howev-
er, until such research is done, our study suggests that
permanent braided suture should not be the first line
material used in vaginal surgeries such as the uterosacral
ligament suspension.
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